Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 24,470 |
|
|||||
| News | - | ||||||
| Day High | 1.68 | Low High |
|||||
| Day Low | 1.62 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Carisma Therapeutics Inc | CARM | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.02 | -1.20% | 1.65 | 11:58:42 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.67 | 1.62 | 1.68 | 1.67 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 428 | 24,470 | $ 1.65 | $ 40,426 | - | 1.53 - 9.7662 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:58:47 | 100 | $ 1.65 | USD |
Carisma Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 66.59M | 40.36M | - | 14.92M | -86.88M | -2.15 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Carisma Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CARM Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.85 | 1.91 | 1.60 | 1.67 | 93,690 | -0.20 | -10.81% |
| 1 Month | 2.07 | 2.10 | 1.53 | 1.84 | 176,894 | -0.42 | -20.29% |
| 3 Months | 2.07 | 2.77 | 1.53 | 2.19 | 168,200 | -0.42 | -20.29% |
| 6 Months | 2.81 | 3.4179 | 1.53 | 2.43 | 170,496 | -1.16 | -41.28% |
| 1 Year | 4.15 | 9.7662 | 1.53 | 4.79 | 223,696 | -2.50 | -60.24% |
| 3 Years | 5.79 | 9.7662 | 1.53 | 4.66 | 217,370 | -4.14 | -71.50% |
| 5 Years | 5.79 | 9.7662 | 1.53 | 4.66 | 217,370 | -4.14 | -71.50% |
Carisma Therapeutics Description
| Carisma Therapeutics Inc. is a clinical-stage cell therapy company. The Company is focused on utilizing the Company¿s macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The Company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells. The Company¿s lead product candidate, CT-0508, is a Chimeric Antigen Receptor Macrophage (CAR-M) to be evaluated in a human clinical trial and is intended to treat solid tumors that overexpress HER2. The Company¿s second product candidate, CT-0525, is also intended to treat solid tumors that overexpress HER2, is in preclinical development. Beyond CT-0508 and CT-0525, the Company has a pipeline of cell therapy assets in various stages of pre-clinical development. The Company is also developing in vivo CAR-M gene therapies. |
